Ibuprofen Lysinate
Important Information for the Patient.
This medication should always be used exactly as described in this patient information leaflet or as advised by a doctor or pharmacist.
The active substance of Metafen Gel Forte is ibuprofen. Ibuprofen belongs to a group of nonsteroidal anti-inflammatory and analgesic drugs. Its mechanism of action involves inhibiting the synthesis of prostaglandins in inflamed tissue. The medication is in the form of a gel, intended for topical application to the skin.
Conditions requiring local analgesic and anti-inflammatory action:
Do not use in children under 12 years of age without a doctor's recommendation.
Before starting to use Metafen Gel Forte, the patient should discuss it with their doctor or pharmacist.
Severe skin reactions, such as exfoliative dermatitis, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized exanthematous pustulosis (AGEP), have been reported with the use of ibuprofen. If the patient experiences any symptoms associated with these severe skin reactions described in section 4, they should immediately discontinue Metafen Gel Forte and seek medical attention.
Particular caution should be exercised when using Metafen Gel Forte in the following cases:
The patient should inform their doctor or pharmacist about all medications they are currently taking or have recently taken, as well as any medications they plan to take.
No interactions between topically applied ibuprofen and other medications are known.
Such interactions cannot be ruled out, given the occurrence of interactions after oral ibuprofen administration.
Like other nonsteroidal anti-inflammatory drugs, oral ibuprofen may interact with blood pressure-lowering medications.
Concomitant use of acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs may increase the frequency of side effects.
Ibuprofen may irreversibly inhibit the antiplatelet aggregation effect of acetylsalicylic acid, limiting the protective effect of this medication on the heart in patients at risk of myocardial infarction.
Concomitant administration of corticosteroids and nonsteroidal anti-inflammatory drugs may increase the risk of gastrointestinal ulcer disease.
There is a possibility of inhibiting platelet aggregation by ibuprofen in patients concomitantly using anticoagulant medications (e.g., warfarin, acenocoumarol) or thrombolytic agents (e.g., streptokinase), which may lead to gastrointestinal bleeding and prolonged blood coagulation time.
Ibuprofen increases lithium levels in the blood, enhances the toxic effects of methotrexate, and reduces the effectiveness of diuretics.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medication.
Metafen Gel Forte should not be used during the last 3 months of pregnancy.
Metafen Gel Forte should not be used during the first 6 months of pregnancy, unless it is absolutely necessary and advised by a doctor. If treatment is necessary during this period, the smallest dose should be used for the shortest possible time.
Oral forms of medications (e.g., Metafen Ibuprofen tablets) containing ibuprofen may cause side effects in the unborn child. It is not known if the same risk applies to Metafen Gel Forte when used on the skin.
No side effects that could affect the ability to drive or operate machinery are known.
The medication may cause allergic reactions (possible late reactions) and, exceptionally, bronchospasm.
This medication should always be used exactly as described in this patient information leaflet or as advised by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
The medication should be applied topically to the skin.
Use in adults and adolescents over 12 years of age:
About 3 cm of gel should be squeezed out and gently rubbed into the affected area until completely absorbed.
The recommended dose should not be exceeded.
Overdose of topically applied ibuprofen is unlikely. If too much gel is applied to the skin, the excess should be washed off with water.
If someone, e.g., a child, accidentally ingests the medication, they should immediately contact a doctor or pharmacist.
If a dose is missed, the treatment should be continued by applying and rubbing in the usual amount of gel into the skin.
A double dose should not be used to make up for a missed dose.
In case of any further doubts about using this medication, the patient should consult their doctor or pharmacist.
Like all medications, Metafen Gel Forte can cause side effects, although not everybody gets them.
If the patient experiences any of the following symptoms, they should immediately stop using ibuprofen and seek medical attention:
Other side effects:
In the case of long-term use on large areas of the body, additional side effects may occur: headaches and dizziness, changes in blood counts (granulocytopenia, agranulocytosis), hyperuricemia, and gastrointestinal disorders such as nausea, vomiting, loss of appetite, and recurrence of stomach and duodenal ulcers. During ibuprofen treatment, kidney damage may also occur, especially in patients with kidney diseases.
If any side effects occur, including those not listed in this leaflet, the patient should inform their doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medication.
Store at a temperature below 25°C.
The medication should be stored out of sight and reach of children.
Do not use this medication after the expiry date stated on the packaging.The expiry date refers to the last day of the month stated.
Shelf life after first opening the package: 6 months.
Medications should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medications that are no longer needed. This will help protect the environment.
An aluminum tube in a cardboard box, containing 50 g or 100 g of gel.
Marketing Authorization Holder
Zakłady Farmaceutyczne POLPHARMA S.A.
ul. Pelplińska 19, 83-200 Starogard Gdański
phone: +48 22 364 61 01
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Medana Branch in Sieradz
ul. Władysława Łokietka 10, 98-200 Sieradz
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.